Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $7.15B | 157,070,575 | 55.24% | 44.76% | Net Selling | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.13B | 137,339,016 | 42.00% | 11.18% | Net Buying | Net Buying | ||
| CORT | CORCEPT THERAPEUTICS INC | $7.58B | 105,503,432 | 30.22% | 69.78% | Net Buying | Net Buying | ||
| KRYS | KRYSTAL BIOTECH INC | $4.89B | 28,806,078 | 78.59% | 21.41% | Net Selling | Net Selling | ||
| NAGE | NIAGEN BIOSCIENCE INC | $610.34M | 77,750,447 | 13.74% | 86.26% | Net Buying | Net Buying | ||
| SPRY | ARS PHARMACEUTICALS INC | $1.37B | 98,119,804 | 44.08% | 55.92% | Net Selling | Net Buying | ||
| GYRE | GYRE THERAPEUTICS INC | $913.66M | 93,612,442 | 1.09% | 98.91% | Net Buying | Net Buying | ||
| ARGX | ARGENX SE | $39.20B | 60,760,957 | 56.15% | 0.00% | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.95B | 121,449,655 | 80.39% | 16.12% | Net Buying | Net Selling | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.69B | 57,345,611 | 71.11% | 28.89% | Net Selling | Net Selling | ||
| VCEL | VERICEL CORP | $1.90B | 49,969,568 | 91.07% | 8.93% | Net Selling | Net Selling | ||
| EXEL | EXELIXIS INC | $10.96B | 279,881,450 | 89.31% | 5.19% | Net Selling | Net Selling | ||
| SRPT | SAREPTA THERAPEUTICS INC | $6.05B | 97,032,073 | 75.52% | 24.48% | Net Selling | Net Selling | ||
| HALO | HALOZYME THERAPEUTICS INC | $7.56B | 123,153,000 | 78.14% | 21.86% | Net Selling | Net Selling | ||
| RIGL | RIGEL PHARMACEUTICALS INC | $349.40M | 17,862,958 | 32.39% | 67.61% | Net Selling | Net Selling | ||
| RPRX | ROYALTY PHARMA PLC | $18.92B | 576,453,167 | 55.47% | 17.23% | Net Buying | Net Buying | ||
| NVO | NOVO NORDISK A S | $296.70B | 4,465,000,000 | 7.56% | 0.00% | ||||
| MDXG | MIMEDX GROUP INC | $1.01B | 147,366,056 | 45.62% | 54.38% | Net Selling | Net Selling | ||
| ADMA | ADMA BIOLOGICS INC | $5.66B | 237,615,100 | 78.41% | 21.59% | Net Selling | Net Selling | ||
| INCY | INCYTE CORP | $12.13B | 193,569,934 | 76.18% | 23.82% | Net Selling | Net Selling | ||
| MNKD | MANNKIND CORP | $1.53B | 303,591,344 | 34.91% | 65.09% | Net Selling | Net Selling | ||
| VCYT | VERACYTE INC | $2.38B | 77,944,772 | 65.76% | 34.24% | Net Selling | Net Selling | ||
| GNFT | GENFIT SA | $204.73M | 49,996,185 | 0.41% | 0.00% | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.10B | 60,732,479 | 27.91% | 72.09% | Net Selling | Net Selling | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $12.15B | 190,777,052 | 95.98% | 1.72% | Net Selling | Net Selling | ||
| TECH | BIO-TECHNE CORP | $7.96B | 158,087,683 | 97.63% | 2.37% | Net Buying | Net Selling | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $2.44B | 166,788,517 | 71.61% | 28.39% | Net Selling | Net Selling | ||
| GMAB | GENMAB A | $14.00B | 66,187,186 | 91.84% | 0.00% | ||||
| UTHR | UNITED THERAPEUTICS CORP | $13.67B | 45,106,623 | 90.81% | 9.19% | Net Selling | Net Buying | ||
| REGN | REGENERON PHARMACEUTICALS INC | $64.65B | 107,965,497 | 69.81% | 30.19% | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.